1125345 - Macrogenics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - MGNX (1125345)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
46 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S7+0+2-0-32

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-03-12
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+1,0009,100+12%+$940
D
2018-03-12
MGNXRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$31.08-1,0009,100-10%-$31,080
2018-03-05
MGNXKarrels JamesSVP, CFO, SecretaryS - Sale$31.00-5,000114,847-4%-$155,000
D
2018-03-02
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+4,0009,100+78%+$3,760
D
2018-03-02
MGNXRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$30.00-4,0009,100-31%-$120,000
D
2018-02-28
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+1,0009,100+12%+$940
D
2018-02-28
MGNXRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$25.00-1,0009,100-10%-$25,005
D
2018-02-28
MGNXCilinski LynnVP, Controller, TreasurerM - OptEx$1.13+23,9671,923-109%+$27,083
D
2018-02-28
MGNXCilinski LynnVP, Controller, TreasurerS - Sale+OE$25.01-23,9671,923-93%-$599,436
2018-02-26
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOF - Tax$23.46-11,07018,930-37%-$259,702
AD
2018-01-24
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+3,0009,100+49%+$2,820
AD
2018-01-24
MGNXRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$22.50-3,0009,100-25%-$67,500
D
2018-01-24
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+3,0009,100+49%+$2,820
D
2018-01-24
MGNXRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$22.50-3,0009,100-25%-$67,500
D
2018-01-16
MGNXKarrels JamesSVP, CFO, SecretaryM - OptEx$0.94+6,516119,847+6%+$6,125
DM
2018-01-16
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+5,00030,000+20%+$23,500
DM
2018-01-16
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-5,00030,000-14%-$100,000
D
2018-01-17
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+2,0009,100+28%+$1,880
D
2017-12-29
MGNXKarrels JamesSVP, CFO, SecretaryM - OptEx$0.94+3,000113,331+3%+$2,820
D
2017-11-21
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+5,00030,000+20%+$23,500
D
2017-11-21
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-5,00030,000-14%-$100,000
D
2017-10-25
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+10,00030,000+50%+$47,000
D
2017-10-25
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-10,00030,000-25%-$200,000
D
2017-09-05
MGNXKarrels JamesSVP, CFO, SecretaryM - OptEx$0.94+5,000110,331+5%+$4,700
D
2017-09-05
MGNXRisser Eric BlasiusSVP, Chief Business OfficerM - OptEx$0.94+2,0006,000+50%+$1,880
D
2017-07-26
MGNXBonvini EzioSVP, Research, CSOM - OptEx$1.23+53,264146,658+57%+$65,248
D
2017-06-05
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+5,00030,000+20%+$23,500
D
2017-06-05
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-5,00030,000-14%-$100,000
2017-04-28
MGNXSaran AtulSVP, GCF - Tax$21.61-1,86216,986-10%-$40,238-3-15
D
2017-04-19
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+15,00030,000+100%+$70,500-1+4
D
2017-04-19
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$20.00-15,00030,000-33%-$300,000-1+4
D
2017-01-25
MGNXKarrels JamesSVP, CFO, SecretaryM - OptEx$0.94+5,000105,331+5%+$4,700+1+1+7
D
2017-01-17
MGNXKoenig ScottPres, CEOM - OptEx$0.94+79,8981,004,358+9%+$75,104+1-4+9
DM
2016-02-11
MGNXBonvini EzioSVP, Research, CSOM - OptEx$0.94+17,311100,944+21%+$16,272-1-7+10-18
AD
2016-10-03
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+10,0000-100%+$47,000+4+2+18-14
AD
2016-10-03
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$29.34-10,0000-100%-$293,400+4+2+18-14
D
2016-10-03
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOM - OptEx$4.70+10,0000-100%+$47,000-1-2-28-43
D
2016-10-03
MGNXWigginton Jon MarcSVP, Clinical Dev., CMOS - Sale+OE$29.34-10,0000-100%-$293,400-1-2-28-43
D
2016-10-03
MGNXCilinski LynnVP, Controller, TreasurerM - OptEx$0.94+6,2311,923-145%+$5,857-1-2-28-43
D
2016-10-03
MGNXCilinski LynnVP, Controller, TreasurerS - Sale+OE$29.28-6,2311,923-76%-$182,444-1-2-28-43
D
2016-08-01
MGNXWigginton Jon MarcSVP Clinical Dev, CMOM - OptEx$4.70+20,0000-100%+$94,000+2-1-6-44
D
2016-08-01
MGNXWigginton Jon MarcSVP Clinical Dev, CMOS - Sale+OE$30.78-20,0000-100%-$615,600+2-1-6-44
D
2016-07-01
MGNXWigginton Jon MarcSVP Clinical Dev, CMOM - OptEx$4.70+5,0000-100%+$23,500-1+5+21-24
D
2016-07-01
MGNXWigginton Jon MarcSVP Clinical Dev, CMOS - Sale+OE$27.22-5,0000-100%-$136,100-1+5+21-24
D
2016-07-01
MGNXCilinski LynnVP, Controller, TreasurerM - OptEx$0.94+8,9221,923-127%+$8,387-1+5+21-24
D
2016-07-01
MGNXCilinski LynnVP, Controller, TreasurerS - Sale+OE$27.22-8,9221,923-82%-$242,857-1+5+21-24

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top